What Happened?
Syracuse, NY-based Quadrant Biosciences Appointed Charles Marra as Vice President of Technology
About the Company
Quadrant Biosciences is an epigenetic diagnostics company with a focus on the early detection of neurological disorders and other large-scale health issues. Revolutionary advancements in the early detection of autism spectrum disorder, Parkinson’s disease, and mTBI, through the application of the Clarifi® epigenetic diagnostic platform, could have a significant impact on the way clinicians approach the diagnosis and treatment of these serious conditions. In March 2020, we made the decision to pivot and allocate some of our resources to directly address the pandemic. By leveraging our expertise in RNA analysis, we have been able to be part of three exciting COVID-19 projects to aid in the detection of COVID-19 in individuals and communities across the U.S.
About the Person
Charles Marra is Vice President of Technology at Quadrant Biosciences. Previously, Charles held various senior IT leadership roles in the industry.
Info Source
News
Short Profile